Getinge AB (publ) (GNGBF)
USD 15.68
(0.0%)
USD 15.68
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.73 Billion SEK | -0.11% |
| 2022 | 3.62 Billion SEK | -17.04% |
| 2021 | 4.37 Billion SEK | -8.63% |
| 2020 | 4.78 Billion SEK | 101.69% |
| 2019 | 2.37 Billion SEK | 935.21% |
| 2018 | -284 Million SEK | -119.02% |
| 2017 | 1.49 Billion SEK | -34.72% |
| 2016 | 2.28 Billion SEK | -16.2% |
| 2015 | 2.72 Billion SEK | 3.14% |
| 2014 | 2.64 Billion SEK | -29.4% |
| 2013 | 3.74 Billion SEK | -6.44% |
| 2012 | 4 Billion SEK | 2.09% |
| 2011 | 3.92 Billion SEK | 6.37% |
| 2010 | 3.68 Billion SEK | 20.16% |
| 2009 | 3.07 Billion SEK | 6.71% |
| 2008 | 2.87 Billion SEK | 26.07% |
| 2007 | 2.28 Billion SEK | 17.87% |
| 2006 | 1.93 Billion SEK | 7.39% |
| 2005 | 1.8 Billion SEK | 3.47% |
| 2004 | 1.74 Billion SEK | 238.67% |
| 2003 | -1.25 Billion SEK | -19.72% |
| 2002 | -1.04 Billion SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 906 Million SEK | 20.0% |
| 2024 Q1 | 755 Million SEK | -40.83% |
| 2024 Q3 | 184 Million SEK | -79.69% |
| 2023 Q2 | 383 Million SEK | -57.49% |
| 2023 Q1 | 901 Million SEK | 8.82% |
| 2023 Q4 | 1.27 Billion SEK | -2.97% |
| 2023 Q3 | 1.31 Billion SEK | 243.34% |
| 2023 FY | 3.62 Billion SEK | -0.11% |
| 2022 Q1 | 780 Million SEK | -29.86% |
| 2022 Q4 | 828 Million SEK | -25.2% |
| 2022 FY | 3.62 Billion SEK | -17.04% |
| 2022 Q3 | 1.1 Billion SEK | 21.51% |
| 2022 Q2 | 911 Million SEK | 16.79% |
| 2021 Q4 | 1.11 Billion SEK | 1.65% |
| 2021 FY | 4.37 Billion SEK | -8.63% |
| 2021 Q3 | 1.09 Billion SEK | -9.21% |
| 2021 Q2 | 1.2 Billion SEK | 25.52% |
| 2021 Q1 | 960 Million SEK | -40.34% |
| 2020 Q4 | 1.6 Billion SEK | -15.89% |
| 2020 Q2 | 757 Million SEK | 49.9% |
| 2020 Q1 | 505 Million SEK | -65.81% |
| 2020 FY | 4.78 Billion SEK | 101.69% |
| 2020 Q3 | 1.91 Billion SEK | 152.71% |
| 2019 Q3 | 433 Million SEK | 33.64% |
| 2019 Q4 | 1.47 Billion SEK | 241.11% |
| 2019 Q1 | 138 Million SEK | -88.58% |
| 2019 Q2 | 324 Million SEK | 134.78% |
| 2019 FY | 2.37 Billion SEK | 935.21% |
| 2018 Q3 | -1.73 Billion SEK | -528.64% |
| 2018 Q2 | 405 Million SEK | 351.55% |
| 2018 Q1 | -161 Million SEK | -130.38% |
| 2018 FY | -284 Million SEK | -119.02% |
| 2018 Q4 | 1.2 Billion SEK | 169.59% |
| 2017 Q3 | 261 Million SEK | 61.11% |
| 2017 FY | 1.49 Billion SEK | -34.72% |
| 2017 Q4 | 530 Million SEK | 103.07% |
| 2017 Q1 | 540 Million SEK | -62.73% |
| 2017 Q2 | 162 Million SEK | -70.0% |
| 2016 Q3 | 49 Million SEK | -89.64% |
| 2016 Q4 | 1.44 Billion SEK | 2857.14% |
| 2016 FY | 2.28 Billion SEK | -16.2% |
| 2016 Q2 | 473 Million SEK | 49.68% |
| 2016 Q1 | 316 Million SEK | -79.55% |
| 2015 FY | 2.72 Billion SEK | 3.14% |
| 2015 Q4 | 1.54 Billion SEK | 266.98% |
| 2015 Q3 | 421 Million SEK | -1.64% |
| 2015 Q2 | 428 Million SEK | 27.76% |
| 2015 Q1 | 335 Million SEK | -78.41% |
| 2014 FY | 2.64 Billion SEK | -29.4% |
| 2014 Q2 | 713 Million SEK | 342.52% |
| 2014 Q1 | -294 Million SEK | -115.82% |
| 2014 Q4 | 1.55 Billion SEK | 129.93% |
| 2014 Q3 | 675 Million SEK | -5.33% |
| 2013 FY | 3.74 Billion SEK | -6.44% |
| 2013 Q4 | 1.85 Billion SEK | 159.86% |
| 2013 Q3 | 715 Million SEK | -7.74% |
| 2013 Q2 | 775 Million SEK | 93.75% |
| 2013 Q1 | 400 Million SEK | -74.86% |
| 2012 Q4 | 1.59 Billion SEK | 87.84% |
| 2012 Q1 | 704 Million SEK | -57.59% |
| 2012 Q2 | 865 Million SEK | 22.87% |
| 2012 FY | 4 Billion SEK | 2.09% |
| 2012 Q3 | 847 Million SEK | -2.08% |
| 2011 Q4 | 1.66 Billion SEK | 106.21% |
| 2011 FY | 3.92 Billion SEK | 6.37% |
| 2011 Q1 | 690 Million SEK | -81.0% |
| 2011 Q2 | 768 Million SEK | 11.3% |
| 2011 Q3 | 805 Million SEK | 4.82% |
| 2010 Q3 | 6 Million SEK | -50.0% |
| 2010 Q2 | 12 Million SEK | -70.0% |
| 2010 Q1 | 40 Million SEK | -98.7% |
| 2010 FY | 3.68 Billion SEK | 20.16% |
| 2010 Q4 | 3.63 Billion SEK | 60416.67% |
| 2009 Q2 | 4 Million SEK | -99.28% |
| 2009 FY | 3.07 Billion SEK | 6.71% |
| 2009 Q1 | 558 Million SEK | 0.0% |
| 2009 Q4 | 3.07 Billion SEK | 252.06% |
| 2009 Q3 | 872 Million SEK | 21700.0% |
| 2008 FY | 2.87 Billion SEK | 26.07% |
| 2007 FY | 2.28 Billion SEK | 17.87% |
| 2006 FY | 1.93 Billion SEK | 7.39% |
| 2005 FY | 1.8 Billion SEK | 3.47% |
| 2004 FY | 1.74 Billion SEK | 238.67% |
| 2003 FY | -1.25 Billion SEK | -19.72% |
| 2002 FY | -1.04 Billion SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AVITA Medical, Inc. | -40.4 Million USD | 9347.045% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | 531536.7% |
| Össur hf. | 87.46 Million USD | -4171.618% |
| QHSLab, Inc. | -240.15 Thousand USD | 1555742.535% |
| Wellstar International, Inc. | -1.79 Million USD | 208268.96% |
| Össur hf. | 87.46 Million USD | -4171.618% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | -104.47 Thousand USD | 3576040.886% |
| Aurora Spine Corporation | -446.19 Thousand USD | 837400.2% |
| BrainsWay Ltd. | -4.92 Million USD | 75927.075% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 1362162.051% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | -1343799.395% |
| Vivos Inc. | -2.79 Million USD | 133855.987% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | 1562194.947% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 210977.818% |
| Zecotek Photonics Inc. | -3.65 Million USD | 102266.638% |
| Avitar, Inc. | 2.73 Million USD | -136609.052% |
| Nanomix Corporation | -8.43 Million USD | 44380.261% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | -179429.073% |
| Theraclion SA | -3.48 Million USD | 107428.564% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | -1.36 Million USD | 274654.474% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | 181025.266% |
| Lombard Medical, Inc. | -29.33 Million USD | 12835.64% |
| ALR Technologies Inc. | -2.94 Million USD | 126902.334% |
| Stratec SE | 25.26 Million USD | -14685.34% |
| Vycor Medical, Inc. | 40.19 Thousand USD | -9295513.446% |
| Heart Tronics, Inc. | 14.46 Million USD | -25736.641% |
| MicroPort Scientific Corporation | -516.16 Million USD | 823.798% |
| VMS Rehab Systems, Inc. | -68.66 USD | 5441305081.066% |
| NewCardio, Inc. | -9.45 Million USD | 39595.786% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 108170.581% |
| Ingen Technologies, Inc. | -1.61 Million USD | 231625.808% |
| Odyssey Group International, Inc. | 14.26 Million USD | -26097.184% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 986096.527% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | 528509.059% |
| SANUWAVE Health, Inc. | -540 Thousand USD | 691951.852% |
| IR-Med Inc. | -4.91 Million USD | 76174.119% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 18122.423% |
| Polarean Imaging plc | -12.55 Million USD | 29854.313% |
| United American Healthcare Corporation | -67 Thousand USD | 5576219.403% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | 916954.815% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | 3099846.113% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | 588735.676% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | 621192.198% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | -852517.646% |
| Urologix, Inc. | -6.93 Million USD | 54010.534% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | 295825.672% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 59732.976% |
| SS Innovations International, Inc. | -20.66 Million USD | 18175.927% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | 1622747.574% |
| Smith & Nephew plc | 425 Million USD | -779.059% |
| NIOX Group Plc | 4.6 Million USD | -81117.391% |
| Fuse Medical, Inc. | 383.82 Thousand USD | -973272.935% |
| Broncus Holding Corporation | -33.22 Million USD | 11345.899% |
| Brain Scientific Inc. | -9.6 Million USD | 38982.616% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 39412.42% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | 6155061.367% |